May 11, 2022 | Daily Business Review
Pfizer to Spend $11.6B on Migraine Treatment Maker BiohavenPfizer is starting to put its COVID-19 cash influx to use to venture deeper into a new treatment area.
By Tom Murphy
3 minute read
May 04, 2022 | Daily Business Review
Pfizer Profit Soars in First Quarter, Revises 2022 ForecastPfizer's COVID-19 vaccine launched in late 2020 and became the drugmaker's top selling product by last year's second quarter.
By Tom Murphy
3 minute read
February 28, 2022 | Daily Business Review
Amazon's Voice Assistant Alexa to Start Seeking Doctor HelpAmazon and telemedicine provider Teladoc Health are starting a voice-activated virtual care program that lets customers get medical help without picking up their phones.
By Tom Murphy and Anne D'Innocenzio
4 minute read
December 13, 2021 | Daily Business Review
Pfizer to Pay $6.7B in Cash for Arena PharmaceuticalsPfizer believes that Arena will bolster its expertise in inflammation and immunology.
By Tom Murphy
2 minute read
November 18, 2021 | Daily Business Review
Pfizer, US Ink $5.29B Deal for Possible COVID-19 TreatmentPfizer reported earlier this month that its pill cut hospitalizations and deaths by 89% among high-risk adults who had early symptoms of COVID-19.
By Tom Murphy
3 minute read
November 12, 2015 | New York Law Journal
Big Deals: Debevoise Advises Activision in $5.9B Purchase of Candy CrushActivision Blizzard, which owns the extraordinarily successful "Call of Duty" series, will pay $5.9 billion to buy Candy Crush maker King Digital Entertainment, combining a console gaming power with an established player in the fast-growing mobile gaming field.
By Tom Murphy
3 minute read
November 11, 2015 | New York Law Journal
Big Deals: Debevoise Advises Activision in $5.9B Purchase of Candy CrushActivision Blizzard, which owns the extraordinarily successful "Call of Duty" series, will pay $5.9 billion to buy Candy Crush maker King Digital Entertainment, combining a console gaming power with an established player in the fast-growing mobile gaming field.
By Tom Murphy
3 minute read
July 09, 2015 | New York Law Journal
Big DealsAetna aims to spend about $35 billion to buy rival Humana and become the latest health insurer bulking up on government business as the industry adjusts to the federal healthcare overhaul.
By Tom Murphy
6 minute read
July 08, 2015 | New York Law Journal
Big DealsAetna aims to spend about $35 billion to buy rival Humana and become the latest health insurer bulking up on government business as the industry adjusts to the federal healthcare overhaul.
By Tom Murphy
6 minute read
January 21, 2014 | Daily Report Online
Insurance Through Work? Health Law Affects You TooThe health care overhaul's reach stretches far beyond the millions of uninsured Americans it is expected to help. It also could touch everything from the drug choices to doctor bills of people who have insurance through work.
By Carla K. Johnson and Tom Murphy
6 minute read
Trending Stories